A phase 3, randomised, observer-blinded, placebo controlled-trial evaluating the safety and immunogenicity of investigational SARS-CoV-2 mRNA vaccine CVnCoV in adult healthcare workers in Mainz (Germany)
一项在德国美因茨进行的 3 期随机、观察者盲法、安慰剂对照试验,旨在评估研究性 SARS-CoV-2 mRNA 疫苗 CVnCoV 在成年医护人员中的安全性和免疫原性。
期刊:Vaccine: X
影响因子:2.2
doi:10.1016/j.jvacx.2024.100512
Kowalzik, Frank; Teschner, Daniel; Mesquita, Margarida; Jensen, Christian; Schreiner, Daniel; Kronfeld, Kai; Tubic-Grozdanis, Marija; Cheatham-Seitz, Darline; Hettich, Franziska; Quintini, Gianluca; Schoenborn-Kellenberger, Oliver; Codó, Paula; von Eisenhart-Rothe, Philipp; Mann, Philipp; Oostvogels, Lidia; Gehring, Stephan